Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon
Top Cited Papers
Open Access
- 1 February 2003
- Vol. 52 (2) , 237-242
- https://doi.org/10.1136/gut.52.2.237
Abstract
Background and aim: The colonic microflora is involved in the pathogenesis of Crohn9s disease (CD) but less than 30% of the microflora can be cultured. We investigated potential differences in the faecal microflora between patients with colonic CD in remission (n=9), patients with active colonic CD (n=8), and healthy volunteers (n=16) using culture independent techniques. Methods: Quantitative dot blot hybridisation with six radiolabelled 16S ribosomal ribonucleic acid (rRNA) targeting oligonucleotide probes was used to measure the proportions of rRNA corresponding to each phylogenetic group. Temporal temperature gradient gel electrophoresis (TTGE) of 16S rDNA was used to evaluate dominant species diversity. Results: Enterobacteria were significantly increased in active and quiescent CD. Probe additivity was significantly lower in patients (65 (11)% and 69 (6)% in active CD and quiescent CD) than in healthy controls (99 (7)%). TTGE profiles varied markedly between active and quiescent CD but were stable in healthy conditions. Conclusion: The biodiversity of the microflora remains high in patients with CD. Enterobacteria were observed significantly more frequently in CD than in health, and more than 30% of the dominant flora belonged to yet undefined phylogenetic groups.Keywords
This publication has 30 references indexed in Scilit:
- Probiotic impact on microbial flora, inflammation and tumour development in IL‐10 knockout miceAlimentary Pharmacology & Therapeutics, 2001
- Protection from gastrointestinal diseases with the use of probioticsThe American Journal of Clinical Nutrition, 2001
- Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics, and ecotherapeuticsGastroenterology, 2001
- Is Lactobacillus GG Helpful in Children With Crohn’s Disease? Results of a Preliminary, Open-Label StudyJournal of Pediatric Gastroenterology and Nutrition, 2000
- Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trialGastroenterology, 2000
- Quantification of Bacterial Groups within Human Fecal Flora by Oligonucleotide Probe HybridizationApplied and Environmental Microbiology, 2000
- Saccharomyces boulardii in Maintenance Treatment of Crohn’s DiseaseDigestive Diseases and Sciences, 2000
- Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trialThe Lancet, 1999
- Lactobacillus species prevents colitis in interleukin 10 gene–deficient miceGastroenterology, 1999
- Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy.1968